ABSTRACT
Tyrosinemia type I (HTI) is treated with nitisinone, a tyrosine (Tyr) and phenylalanine (Phe)-restricted diet, and supplemented with a Tyr/Phe-free protein substitute (PS). Casein glycomacropeptide (CGMP), a bioactive peptide, is an alternative protein source to traditional amino acids (L-AA). CGMP contains residual Tyr and Phe and requires supplementation with tryptophan, histidine, methionine, leucine, cysteine and arginine. AIMS: a 2-part study assessed: (1) the tolerance and acceptability of a low Tyr/Phe CGMP-based PS over 28 days, and (2) its long-term impact on metabolic control and growth over 12 months. METHODS: 11 children with HTI were recruited and given a low Tyr/Phe CGMP to supply all or part of their PS intake. At enrolment, weeks 1 and 4, caregivers completed a questionnaire on gastrointestinal symptoms, acceptability and ease of PS use. In study part 1, blood Tyr and Phe were assessed weekly; in part 2, weekly to fortnightly. In parts 1 and 2, weight and height were assessed at the study start and end. RESULTS: Nine of eleven children (82%), median age 15 years (range 8.6-17.7), took low Tyr/Phe CGMP PS over 28 days; it was continued for 12 months in n = 5 children. It was well accepted by 67% (n = 6/9), tolerated by 100% (n = 9/9) and improved gastrointestinal symptoms in 2 children. The median daily dose of protein equivalent from protein substitute was 60 g/day (range 45-60 g) with a median of 20 g/day (range 15 to 30 g) from natural protein. In part 2 (n = 5), a trend for improved blood Tyr was observed: 12 months pre-study, median Tyr was 490 µmol/L (range 200-600) and Phe 50 µmol/L (range 30-100); in the 12 months taking low Tyr/Phe CGMP PS, median Tyr was 430 µmol/L (range 270-940) and Phe 40 µmol/L (range 20-70). Normal height, weight and BMI z scores were maintained over 12 months. CONCLUSIONS: In HTI children, CGMP was well tolerated, with no deterioration in metabolic control or growth when studied over 12 months. The efficacy of CGMP in HTI needs further investigation to evaluate the longer-term impact on blood Phe concentrations and its potential influence on gut microflora.
Subject(s)
Caseins/administration & dosage , Peptide Fragments/administration & dosage , Tyrosinemias/diet therapy , Adolescent , Amino Acids/administration & dosage , Amino Acids/blood , Child , Child, Preschool , Cyclohexanones/administration & dosage , Diet/methods , Dietary Proteins/administration & dosage , Dietary Supplements , Female , Humans , Male , Nitrobenzoates/administration & dosage , Phenylalanine/administration & dosage , Phenylalanine/blood , Prospective Studies , Tyrosine/administration & dosage , Tyrosine/bloodABSTRACT
In a longitudinal retrospective study, we aimed to assess natural protein (NP) tolerance and metabolic control in a cohort of 20 Hereditary Tyrosinaemia type I (HTI) patients. Their median age was 12 years ([3.2-17.7 years], n = 11 female, n = 8 Caucasian, n = 8 Asian origin, n = 2 Arabic and n = 2 Indian). All were on nitisinone (NTBC) with a median dose of 0.7 g/kg/day (range 0.4-1.5 g/kg/day) and were prescribed a tyrosine (Tyr)/phenylalanine (Phe)-restricted diet supplemented with Tyr/Phe-free L-amino acids. Data were collected on clinical signs at presentation, medical history, annual dietary prescriptions, and blood Phe and Tyr levels from diagnosis until transition to the adult service (aged 16-18 years) or liver transplantation (if it preceded transition). The median age of diagnosis was 2 months (range: 0 to 24 months), with n = 1 diagnosed by newborn screening, n = 3 following phenylketonuria (PKU) screening and n = 7 by sibling screening. Five patients were transplanted (median age 6.3 years), and one died due to liver cancer. The median follow-up was 10 years (3-16 years), and daily prescribed NP intake increased from a median of 5 to 24 g/day. Lifetime median blood Tyr (370 µmol/L, range 280-420 µmol/L) and Phe (50 µmol/L, 45-70 µmol/L) were maintained within the target recommended ranges. This cohort of HTI patients were able to increase the daily NP intake with age while maintaining good metabolic control. Extra NP may improve lifelong adherence to the diet.
Subject(s)
Amino Acids, Neutral/administration & dosage , Child Nutritional Physiological Phenomena/physiology , Cyclohexanones/administration & dosage , Dietary Supplements , Nitrobenzoates/administration & dosage , Tyrosinemias/diet therapy , Tyrosinemias/drug therapy , Adolescent , Child , Child, Preschool , Female , Humans , Infant , Infant, Newborn , Longitudinal Studies , Male , Patient Compliance , Phenylalanine/blood , Retrospective Studies , Tyrosine/blood , Tyrosinemias/blood , Tyrosinemias/geneticsABSTRACT
An array of dissociative novel psychoactive substances, including "methoxetamine," "3-MeO-PCP," and "methoxphenidine," have emerged as substitutes for the illicit substance "ketamine." A netographic research methodology aimed to describe online, dissociative novel psychoactive substance users' perceptions of risk, informed knowledge around use, and indigenous harm-reduction practices as advocated within online drug fora, so as to provide credible information which can be used to inform public online health education and drug prevention. Systematic Internet searches were performed using the terms "synthetic dissociative," "methoxetamine," "methoxphenidine," "diphenidine," "3-MeO-PCP," "4-MeO-PCP," "2-MDP," and "dissociative research chemical" in combination with "forum." Following screening of 3,476 forum threads with removal of duplicates and exclusion criteria, 90 user trip reports and 115 fora threads from seven drug fora websites were analyzed by conducting content analysis. Five themes emerged with 43 categories. The findings illustrated how forum activity within the cyber drug user community disseminated and exchanged "communal folk pharmacology" relating to the use of dissociative novel psychoactive substances. Further research and consistent monitoring of Internet drug fora are advised to explore variations in harm-reduction tactics throughout dissociative NPS populations, and to consider how existing harm-reduction initiatives are influencing these hard-to-reach groups.
Subject(s)
Designer Drugs/administration & dosage , Illicit Drugs/adverse effects , Substance-Related Disorders/epidemiology , Cyclohexanones/administration & dosage , Cyclohexanones/adverse effects , Cyclohexylamines/administration & dosage , Cyclohexylamines/adverse effects , Designer Drugs/adverse effects , Designer Drugs/chemistry , Harm Reduction , Humans , Illicit Drugs/chemistry , Phencyclidine/administration & dosage , Phencyclidine/adverse effects , Phencyclidine/analogs & derivatives , Piperidines/administration & dosage , Piperidines/adverse effects , Substance-Related Disorders/prevention & controlABSTRACT
Zanthoxylum schinifolium Sieb. et Zucc. (Rutaceae), a dioecious shrub with hooked prickly branches, has been used as folk medicine for the treatment of the common cold, stomach ache, diarrhea, and jaundice in China, Korea, and Japan. In our phytochemical investigations on this genus, a new megastigmane sesquiterpenoid, which is referred to as schinifolenol A (1), was isolated from Z. schinifolium. The stereochemistry was characterized via the analyses of extensive spectra. The absolute configuration was established by the application of a modified Mosher's experiment and assisted by a time-dependent density functional theory (TD-DFT) on calculated electronic circular dichroism (ECD). Bioactivity screenings showed that compound 1 exhibited a safe hypotoxicity and a better selectivity on anti-Kaposi's sarcoma associated herpes virus (KSHV).
Subject(s)
Cyclohexanones/administration & dosage , Glucosides/administration & dosage , Herpesvirus 8, Human/drug effects , Norisoprenoids/administration & dosage , Sarcoma, Kaposi/drug therapy , Zanthoxylum/chemistry , Circular Dichroism , Cyclohexanones/chemistry , Glucosides/chemistry , Herpesvirus 8, Human/pathogenicity , Humans , Molecular Structure , Norisoprenoids/chemistry , Phytochemicals/administration & dosage , Phytochemicals/chemistry , Plant Extracts/chemistry , Sarcoma, Kaposi/virologyABSTRACT
Two Carthamus tinctorius varieties (Jawhara and 104) were studied in order to investigate their natural dyes contents and biological activities. Obtained results showed that quinochalcone contents and antioxidant activities varied considerably as function of flowering stages. So flowers at fructification stage contained the highest carthamin content with the strongest antioxidant capacity with all assays (FRAP, DPPH, and chelating power methods). In parallel, we showed a decrease in the content of precarthamin. The quantitative variation of these molecules could be due to colour change of C. tinctorius flowers. Correlation analysis indicated that the ABTS method showed the highest correlation coefficients with carthamin and precarthamin contents, that is, 0.886 and 0.973, respectively. Concerning the regional effect, the contents of precarthamin and carthamin varied significantly (P < 0.05) at studied regions with the optimum production given by samples of Beja (902.41 µg/g DW and 42.05 µg/g DW, respectively, at flowering stage). During flowering, the antimicrobial activity of these two natural dyes increased where the maximum inhibitory effect mentioned with carthamin mainly against E. coli (iz = 25.89 mm) at fructification stage. Therefore, the increased frequency of resistance to commonly used antibiotics leads to the search for new effective natural drugs at food and pharmaceutical industries.
Subject(s)
Anti-Bacterial Agents/administration & dosage , Antifungal Agents/administration & dosage , Antioxidants/administration & dosage , Plant Extracts/administration & dosage , Anti-Bacterial Agents/chemistry , Antifungal Agents/chemistry , Antioxidants/chemistry , Bacteria/drug effects , Carthamus/chemistry , Chalcone/administration & dosage , Chalcone/analogs & derivatives , Chalcone/chemistry , Cyclohexanones/administration & dosage , Cyclohexanones/chemistry , Flowers/chemistry , Free Radical Scavengers/administration & dosage , Free Radical Scavengers/chemistry , Fungi/drug effects , Glucosides/administration & dosage , Glucosides/chemistry , Plant Extracts/chemistryABSTRACT
BACKGROUND AND PURPOSE: Inflammation is involved in the development and/or progression of many diseases including diabetic complications. Investigations on novel anti-inflammatory agents may offer new approaches for the prevention of diabetic nephropathy. Our previous bioscreening of synthetic analogues of curcumin revealed C66 as a novel anti-inflammatory compound against LPS challenge in macrophages. In this study, we hypothesized that C66 affects high glucose (HG)-induced inflammation profiles in vitro and in vivo and then prevents renal injury in diabetic rats via its anti-inflammatory actions. EXPERIMENTAL APPROACH: Primary peritoneal macrophages (MPM), prepared from C57BL/6 mice, were treated with HG in the presence or absence of C66. Diabetes was induced in Sprague-Dawley rats with streptozotocin, and the effects of C66 (0.2, 1.0 or 5.0 mg·kg(-1) ), administered daily for 6 weeks, on plasma TNF-α levels and expression of inflammatory genes in the kidney were assessed. KEY RESULTS: Pretreatment of MPMs with C66 reduced HG-stimulated production of TNF-α and NO, inhibited HG-induced IL-1ß, TNF-α, IL-6, IL-12, COX-2 and iNOS mRNA transcription, and the activation of JNK/NF-kB signalling. In vivo, C66 inhibited the increased plasma TNF-α levels and renal inflammatory gene expression, improved histological abnormalities and fibrosis of diabetic kidney, but did not affect the hyperglycaemia in these diabetic rats. CONCLUSIONS AND IMPLICATIONS: The anti-inflammatory effects of C66 are mediated by inhibiting HG-induced activation of the JNK/NF-κB pathway, rather than by reducing blood glucose in diabetic rats. This novel compound is a potential anti-inflammatory agent and might be beneficial for the prevention of diabetic nephropathy.
Subject(s)
Anti-Inflammatory Agents, Non-Steroidal/therapeutic use , Benzylidene Compounds/therapeutic use , Curcumin/therapeutic use , Cyclohexanones/therapeutic use , Diabetes Mellitus, Experimental/drug therapy , Diabetic Nephropathies/prevention & control , Glucose/administration & dosage , Macrophages, Peritoneal/drug effects , Animals , Anti-Inflammatory Agents, Non-Steroidal/administration & dosage , Anti-Inflammatory Agents, Non-Steroidal/pharmacology , Benzylidene Compounds/administration & dosage , Benzylidene Compounds/chemistry , Benzylidene Compounds/pharmacology , Blood Glucose/analysis , Blotting, Western , Body Weight/drug effects , Cell Culture Techniques , Cell Movement/drug effects , Cell Movement/immunology , Curcumin/administration & dosage , Curcumin/analogs & derivatives , Curcumin/pharmacology , Cyclohexanones/administration & dosage , Cyclohexanones/chemistry , Cyclohexanones/pharmacology , Cytokines/blood , Cytokines/immunology , Diabetes Mellitus, Experimental/complications , Diabetes Mellitus, Experimental/enzymology , Diabetes Mellitus, Experimental/pathology , Diabetic Nephropathies/enzymology , Diabetic Nephropathies/immunology , Diabetic Nephropathies/pathology , Dose-Response Relationship, Drug , Fibrosis , Macrophages, Peritoneal/immunology , Male , Mice , Mice, Inbred C57BL , Organ Size/drug effects , Rats , Rats, Sprague-Dawley , Real-Time Polymerase Chain ReactionABSTRACT
In field experiments carried out during the 1997-2001 period on four different soil types (sand, sandy loam, heavy sandy loam and clay) in Flanders (Belgium), the persistence of the three 4-HPPD inhibiting maize herbicides mesotrione (100 and 150 g ha-1), sulcotrione (300 and 450 g ha-1) and isoxaflutole (75 and 125 g ha-1) was studied. Therefore, soil samples were taken at regular intervals from application in spring and frozen. When all samples had been taken, greenhouse bioassays were set up to detect herbicide residues in the different soil types. Therefore, two extremely sensitive test plants, sugarbeet (Beta vulgaris L. spp. altissima Doell. var. saccharifera Deck.-Dill) and red clover (Trifolium pratense L.) were sown in the soil samples. Test plants were harvested after 2 (sugarbeet) and 3 (red clover) weeks and foliage fresh weight per plant was determined. This parameter was expressed relatively to the average fresh weight per plant of the plants sown in the control soil samples taken at each sampling date. The bioassays revealed several factors that influence the persistence of the herbicide tested. First, there is a remarkable influence of the experimental year due to variation in weather conditions (especially rainfall and temperature during the first weeks after spraying). Secondly, a different soil texture results in a highly different persistence: the shortest biological persistence was noticed each year in clay, followed by heavy sandy loam; the longest persistence was recorded in sandy and sandy loam soil types. Thirdly, there are important differences between the three herbicides tested: isoxaflutole (a member of the isoxazole chemical family) was shown to be less persistent than sulcotrione and mesotrione (both members of the triketone family). Remarkably, this was not the case in clay, where a longer persistence could be seen for isoxaflutole compared to sulcotrione and mesotrione. This study also revealed that applying a low rate results in a shorter persistence period compared to the higher rate. All these factors work together in a complex way which determines the persistence of the three herbicides tested.
Subject(s)
4-Hydroxyphenylpyruvate Dioxygenase/metabolism , Herbicides/pharmacology , Pesticide Residues/metabolism , Soil Pollutants/metabolism , Soil/analysis , 4-Hydroxyphenylpyruvate Dioxygenase/antagonists & inhibitors , Aluminum Silicates , Belgium , Beta vulgaris/drug effects , Clay , Cyclohexanones/administration & dosage , Cyclohexanones/pharmacology , Herbicides/administration & dosage , Isoxazoles/administration & dosage , Isoxazoles/pharmacology , Mesylates/administration & dosage , Mesylates/pharmacology , Pesticide Residues/analysis , Plant Leaves/drug effects , Rain , Silicon Dioxide , Temperature , Trifolium/drug effects , WeatherABSTRACT
In continuation of an ongoing program on developing nonsteroidal pregnancy interceptives to be used as a menses regulating agent, a new class of compounds belonging to 3-substituted amino-1-aryl-6-hydroxy-hex-2-ene-1-ones series has been investigated for pregnancy interceptive activity in the hamster and rat. The compounds were administered (subcutaneous) on days 4-8 (hamster) and 5-9 (rat) post coitum (PC). The animals were laparotomized on days 12 (hamster) and 16 (rat) PC. To derive percent efficacy, the total number of implantation was divided by the number of normal and resorbed implantations. Among the 14 compounds evaluated, three were found to intercept pregnancy by 100%. Another compound was active by 75%, whereas the rest were inactive. None of the active compounds were, however, active in rat with this schedule. Results indicate that the observed species- and schedule-specific activity owes its origins to differences in the implantation physiology and early post-implantation development between the two species. The study, nevertheless, offers an insight to the new class of compounds for this activity.